Volume 114, Issue 6 , Pages 1345-1352, December 2004
CD8+ αβ T cells can mediate late airway responses and airway eosinophilia in rats
Background
The function of CD8+ T-cell subsets in mediating late allergic responses is incompletely understood.
Objective
We sought to test the hypothesis that CD8+ αβ T cells are proinflammatory in the airways in vivo by using a well-characterized animal model and the technique of adoptive transfer
Methods
Brown Norway rats were administered CD8+ αβ T cells (106) intraperitoneally purified from lymph node cells of either naive or ovalbumin (OVA)–sensitized rats and were challenged with aerosolized OVA 2 days later. Control rats were sensitized to 100 μg of OVA in Al(OH)3 subcutaneously or sham sensitized to saline and were OVA challenged 2 weeks later.
Results
The OVA-sensitized and OVA-challenged group and the recipients of OVA-primed CD8+ αβ T cells had significant late airway responses calculated from lung resistance measured for an 8-hour period after challenge compared with the naive CD8+ αβ T cell–transferred group and the sham-sensitized control group. The number of eosinophils in bronchoalveolar lavage fluid increased in the OVA-sensitized group and the OVA-primed CD8+ αβ T-cell recipients compared with numbers in the naive CD8+ αβ T-cell recipients and the sham-sensitized control group. IL-4 and IL-5 cytokine mRNA expression in bronchoalveolar lavage fluid increased in the OVA-sensitized group and the OVA-primed CD8+ αβ T-cell recipients compared with that in the sham-sensitized group.
Conclusion
We conclude that antigen-primed CD8+ αβ T cells might have a proinflammatory role in allergen-driven airway responses in the rat.
Key words: Lung, allergy, inflammation, T lymphocytes, cytokines
Abbreviations used: AHR, Airway hyperresponsiveness, BAL, Bronchoalveolar lavage, BN, Brown Norway, EAR, Early airway response, LAR, Late airway response, MACS, Magnetic cell sorting, MBP, Major basic protein, OVA, Ovalbumin, RL, Lung resistance, TCR, T-cell receptor
Supported by Canadian Institutes for Health Research Grant 10381.
PII: S0091-6749(04)02476-5
doi:10.1016/j.jaci.2004.09.021
© 2004 American Academy of Allergy, Asthma and Immunology. Published by Elsevier Inc. All rights reserved.
Volume 114, Issue 6 , Pages 1345-1352, December 2004
